Pharmacological management of neurobehavioral disorders following traumatic brain injury
(TBI) is common practice. However, the evidence available to guide this practice remains …

There is currently a lack of evidence-based guidelines to guide the pharmacological
treatment of neurobehavioral problems that commonly occur after traumatic brain injury …

Traumatic brain injury (TBI) is a significant public health problem that affects millions of
people annually in the USA. Neuropsychiatric symptoms such as cognitive deficits …

There are nearly 1.8 million annual emergency room visits and over 289,000 annual
hospitalizations related to traumatic brain injury (TBI). The goal of this review article is to …

Opinion statement Traumatic brain injury (TBI) may produce a variety of neuropsychiatric
problems, including impaired cognition, depression, mania, affective lability, irritability …

Early pharmacological treatment has the potential to reduce some of the disabling cognitive
and behavioral problems that result from traumatic brain injury (TBI). Although a large …

Pharmacological treatments that are administered to adults in the postacute stage after a
traumatic brain injury (TBI)(≥ 4 weeks after injury) have the potential to reduce persistent …

The pathophysiology of traumatic brain injury (TBI) can be highly variable, involving
functional and/or structural damage to multiple neuroanatomical networks and …

Background: Traumatic brain injury (TBI) can give rise to a variety of neuropsychiatric
syndromes. The objective of this review is to describe the neurobiological mechanisms that …

Traumatic brain injury (TBI) causes a wide variety of neuropsychiatric disturbances
associated with great functional impairments and low quality of life. These disturbances …